Two classes of biologics used to control the symptoms of IBD include anti-TNF medications that block the protein and anti-integrin therapy that inhibits lymphocytes from binding to the lining of the gastrointestinal tract. The gene discussed is TNF; the disease is inflammatory bowel disease.